Predicting cancer immunotherapy response from gut microbiomes using machine learning models

Cancer immunotherapy has significantly improved patient survival. Yet, half of patients do not respond to immunotherapy. Gut microbiomes have been linked to clinical responsiveness of melanoma patients on immunotherapies; however, different taxa have been associated with response status with implica...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hai, Jo, Jay-Hyun, Zhang, Zhiwei, MacGibeny, Margaret A., Han, Jungmin, Proctor, Diana M., Taylor, Monica E., Che, You, Juneau, Paul, Apolo, Andrea B., McCulloch, John A., Davar, Diwakar, Zarour, Hassane M., Dzutsev, Amiran K., Brownell, Isaac, Trinchieri, Giorgio, Gulley, James L., Kong, Heidi H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295706/
https://www.ncbi.nlm.nih.gov/pubmed/35875611
http://dx.doi.org/10.18632/oncotarget.28252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295706/
https://www.ncbi.nlm.nih.gov/pubmed/35875611
http://dx.doi.org/10.18632/oncotarget.28252

Ejemplares similares